Cargando…
Selenium Nanoparticles Based on Morinda officinalis Polysaccharides: Characterization, Anti-Cancer Activities, and Immune-Enhancing Activities Evaluation In Vitro
Recently, selenium nanoparticles have been drawing attention worldwide, and it is crucial to increase the stability of nano-Se. Morinda officinalis polysaccharides (MOP) are the main active component in Morinda officinalis radix. However, their low activity has limited their application. A novel sel...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10052065/ https://www.ncbi.nlm.nih.gov/pubmed/36985397 http://dx.doi.org/10.3390/molecules28062426 |
_version_ | 1785015059969212416 |
---|---|
author | Yao, Mengxin Deng, Yuan Zhao, Zhimin Yang, Depo Wan, Guohui Xu, Xinjun |
author_facet | Yao, Mengxin Deng, Yuan Zhao, Zhimin Yang, Depo Wan, Guohui Xu, Xinjun |
author_sort | Yao, Mengxin |
collection | PubMed |
description | Recently, selenium nanoparticles have been drawing attention worldwide, and it is crucial to increase the stability of nano-Se. Morinda officinalis polysaccharides (MOP) are the main active component in Morinda officinalis radix. However, their low activity has limited their application. A novel selenium nanoparticle (Se-MOP) was prepared to solve these problems using MOP as a dispersant. The zeta potential was measured to evaluate the stability, and UV and ATR-FTIR were used to investigate the binding type of selenium and MOP. The morphology was observed by the TEM method. Furthermore, the inhibitory effect on five selected cancer cells (HepG2, MCF-7, AGS, PC9, and HCT8) was evaluated, showing remarkable inhibition of all five cancer cells. The mechanism of inhibition was also investigated by cell circle assay, and it was found that Se-MOP could induce cell circle G0/G1 phase arrest. Immune-enhancing activities were evaluated by measuring the proliferation and cytokines of mouse spleen lymphocytes in vitro and quantitative RT-PCR. The results indicated that single stimulation of Se-MOP and synergistic stimulation with PHA or LPS increased immune capacity and improved immune by increasing the expression of cytokines. |
format | Online Article Text |
id | pubmed-10052065 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-100520652023-03-30 Selenium Nanoparticles Based on Morinda officinalis Polysaccharides: Characterization, Anti-Cancer Activities, and Immune-Enhancing Activities Evaluation In Vitro Yao, Mengxin Deng, Yuan Zhao, Zhimin Yang, Depo Wan, Guohui Xu, Xinjun Molecules Article Recently, selenium nanoparticles have been drawing attention worldwide, and it is crucial to increase the stability of nano-Se. Morinda officinalis polysaccharides (MOP) are the main active component in Morinda officinalis radix. However, their low activity has limited their application. A novel selenium nanoparticle (Se-MOP) was prepared to solve these problems using MOP as a dispersant. The zeta potential was measured to evaluate the stability, and UV and ATR-FTIR were used to investigate the binding type of selenium and MOP. The morphology was observed by the TEM method. Furthermore, the inhibitory effect on five selected cancer cells (HepG2, MCF-7, AGS, PC9, and HCT8) was evaluated, showing remarkable inhibition of all five cancer cells. The mechanism of inhibition was also investigated by cell circle assay, and it was found that Se-MOP could induce cell circle G0/G1 phase arrest. Immune-enhancing activities were evaluated by measuring the proliferation and cytokines of mouse spleen lymphocytes in vitro and quantitative RT-PCR. The results indicated that single stimulation of Se-MOP and synergistic stimulation with PHA or LPS increased immune capacity and improved immune by increasing the expression of cytokines. MDPI 2023-03-07 /pmc/articles/PMC10052065/ /pubmed/36985397 http://dx.doi.org/10.3390/molecules28062426 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Yao, Mengxin Deng, Yuan Zhao, Zhimin Yang, Depo Wan, Guohui Xu, Xinjun Selenium Nanoparticles Based on Morinda officinalis Polysaccharides: Characterization, Anti-Cancer Activities, and Immune-Enhancing Activities Evaluation In Vitro |
title | Selenium Nanoparticles Based on Morinda officinalis Polysaccharides: Characterization, Anti-Cancer Activities, and Immune-Enhancing Activities Evaluation In Vitro |
title_full | Selenium Nanoparticles Based on Morinda officinalis Polysaccharides: Characterization, Anti-Cancer Activities, and Immune-Enhancing Activities Evaluation In Vitro |
title_fullStr | Selenium Nanoparticles Based on Morinda officinalis Polysaccharides: Characterization, Anti-Cancer Activities, and Immune-Enhancing Activities Evaluation In Vitro |
title_full_unstemmed | Selenium Nanoparticles Based on Morinda officinalis Polysaccharides: Characterization, Anti-Cancer Activities, and Immune-Enhancing Activities Evaluation In Vitro |
title_short | Selenium Nanoparticles Based on Morinda officinalis Polysaccharides: Characterization, Anti-Cancer Activities, and Immune-Enhancing Activities Evaluation In Vitro |
title_sort | selenium nanoparticles based on morinda officinalis polysaccharides: characterization, anti-cancer activities, and immune-enhancing activities evaluation in vitro |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10052065/ https://www.ncbi.nlm.nih.gov/pubmed/36985397 http://dx.doi.org/10.3390/molecules28062426 |
work_keys_str_mv | AT yaomengxin seleniumnanoparticlesbasedonmorindaofficinalispolysaccharidescharacterizationanticanceractivitiesandimmuneenhancingactivitiesevaluationinvitro AT dengyuan seleniumnanoparticlesbasedonmorindaofficinalispolysaccharidescharacterizationanticanceractivitiesandimmuneenhancingactivitiesevaluationinvitro AT zhaozhimin seleniumnanoparticlesbasedonmorindaofficinalispolysaccharidescharacterizationanticanceractivitiesandimmuneenhancingactivitiesevaluationinvitro AT yangdepo seleniumnanoparticlesbasedonmorindaofficinalispolysaccharidescharacterizationanticanceractivitiesandimmuneenhancingactivitiesevaluationinvitro AT wanguohui seleniumnanoparticlesbasedonmorindaofficinalispolysaccharidescharacterizationanticanceractivitiesandimmuneenhancingactivitiesevaluationinvitro AT xuxinjun seleniumnanoparticlesbasedonmorindaofficinalispolysaccharidescharacterizationanticanceractivitiesandimmuneenhancingactivitiesevaluationinvitro |